Your browser doesn't support javascript.
loading
Novel, potent and selective anilinoquinazoline and anilinopyrimidine inhibitors of p38 MAP kinase.
Cumming, John G; McKenzie, Caroline L; Bowden, Stuart G; Campbell, Douglas; Masters, David J; Breed, Jason; Jewsbury, Philip J.
Affiliation
  • Cumming JG; AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK. john.cumming@astrazeneca.com
Bioorg Med Chem Lett ; 14(21): 5389-94, 2004 Nov 01.
Article in En | MEDLINE | ID: mdl-15454232
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Quinazolines / P38 Mitogen-Activated Protein Kinases / Aniline Compounds Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2004 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Quinazolines / P38 Mitogen-Activated Protein Kinases / Aniline Compounds Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2004 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom